EBRO 2017

Surgery vs. surgery + adjuvant chemotherapy, radiotherapy, CRT

EBRO 2017

Pennathur et al, Lancet 2013

• Rationale: may be beneficial for specific subgroups (node-positive disease; positive margins) • No consistent benefits